Precision Cardiovascular Ltd. Revenue and Competitors

Precision Cardiovascular is building the tools to revolutionise the management of heart failure and other cardiac conditions. Early Emergency Assessment. We enable physicians of patients needing to be rushed to hospital intensive care to identify such impending emergencies up to two weeks in advance, allowing for individually tailored treatment to eliminate the need for emergency hospital admissions.High Throughput Personalised Medication, with Improved Outcomes. We enable heart specialists, consultants and practitioners address larger numbers of patients with personalised medication and improved outcomes using our algorithmic data highlights and live round-the-clock high-accuracy response measurements.Reduced costs. Hospitals and insurers benefit from lower costs and streamlined admissions.The company expects to reach full readiness for First-in-Human trials by the end of 2023.